Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Hematology & Oncology Physician in San Luis Obispo, CA
NPI: 1124068515Primary Practice Location
Slo Oncology & Hematology Health Center
715 Tank Farm Rd, San Luis Obispo, CA
Primary Employer
Slo Oncology & Hematology Health Center
dignityhealth.org
HQ Phone
Get M.D., M.H.S. Gorgun's Phone Numberphone_androidMobile
Get M.D., M.H.S. Gorgun's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardAZ State Medical License
CA State Medical License
CA State Medical License
2017 - 2025
IL State Medical License
2015 - 2023
DE State Medical License
2017 - 2021
AZ State Medical License
2012 - 2017
MD State Medical License
2003 - 2014
MA State Medical License
2010 - 2011
American Board of Internal Medicine
Internal Medicine
American Board of Internal Medicine
Hematology
American Board of Internal Medicine
Medical Oncology
Johns Hopkins University
Master of Health Sciences • Clinical investigation
Until 2005
Boston University Medical Center
Fellowship • Hematology and Medical Oncology
1995 - 1998
Hacettepe University FOM
Medical School
Until 1985
The Johns Hopkins University School of Medicine
hopkinsmedicine.org
1998 - 1999
1998 - 1999
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 302 | 624 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 191 | 450 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 85 | 154 |
| 4 | 99204New patient office or other outpatient visit, 45-59 minutes | 68 | 68 |
| 5 | 99443Physician telephone patient service, 21-30 minutes of medical discussion | 61 | 95 |
Authors: Raymond Comenzo
Journal: Br J Haematol
Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome.
Authors: Goyal SD, Zhang M, Wang H, Akpek G, Copelan EA, Freytes C, Gale RP, Hamadani M, Inamoto Y, Kamble RT, Lazarus HM, Marks DI, Nishihori T, Olsson RF, Reshef R, Ritchie DS, Saber W, Savani BN, Seber A, Shea TC, Tallman MS, Wirk B, Bunjes DW, Devine SM, de Lima M, Weisdorf DJ, Uy GL
Publication Date: 2015-08
Authors: Joseph, Ranjit, Shvartsbeyn, Marianna, Günay, Canan, Akpek, Görgün, Aurelian, Laure
Journal: Dermatology
Publication Date: 2013-11-06
Lead Sponsor: Medical College of Wisconsin
Collaborators: National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI), Blood and Marrow Transplant Clinical Trials Network, National Marrow Donor Program
Intervention / Treatment: DRUG: Cytarabine, DRUG: Etoposide, PROCEDURE: Autologous transplant, DRUG: Melphalan, DRUG: BCNU
Lead Sponsor: Medical College of Wisconsin
Collaborators: National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI), Blood and Marrow Transplant Clinical Trials Network, National Marrow Donor Program
Intervention / Treatment: DRUG: Sirolimus + prednisone, DRUG: Sirolimus + calcineurin inhibitor + prednisone
